Author:
Liu Haiyan E.,Vuppalapaty Meghah,Wilkerson Charles,Renier Corinne,Chiu Michael,Lemaire Clementine,Che James,Matsumoto Melissa,Carroll James,Crouse Steve,Hanft Violet R.,Jeffrey Stefanie S.,Di Carlo Dino,Garon Edward B.,Goldman Jonathan,Sollier Elodie
Reference37 articles.
1. Cancer statistics.;Siegel;CA Cancer J Clin.,2020
2. ESMO Guidelines Working Group Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.;Crinò;Ann Oncol Suppl.,2010
3. EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII).;Midha;Am J Cancer Res.,2015
4. Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC).;Gelatti;Lung Cancer.,2019
5. Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.;Bethune;J Thorac Dis.,2010
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献